Everhart Financial Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $978K | Buy |
1,823
+538
| +42% | +$289K | 0.11% | 121 |
|
|
2025
Q1 | $540K | Buy |
1,285
+539
| +72% | +$226K | 0.07% | 191 |
|
|
2024
Q4 | $308K | Sell |
746
-213
| -22% | -$88.1K | 0.06% | 253 |
|
|
2024
Q3 | $485K | Sell |
959
-235
| -20% | -$119K | 0.11% | 196 |
|
|
2024
Q2 | $582K | Buy |
1,194
+214
| +22% | +$104K | 0.15% | 138 |
|
|
2024
Q1 | $529K | Buy |
980
+68
| +7% | +$36.7K | 0.15% | 140 |
|
|
2023
Q4 | $506K | Buy |
912
+132
| +17% | +$73.3K | 0.18% | 112 |
|
|
2023
Q3 | $341K | Sell |
780
-13
| -2% | -$5.69K | 0.14% | 139 |
|
|
2023
Q2 | $398K | Buy |
793
+27
| +4% | +$13.6K | 0.16% | 120 |
|
|
2023
Q1 | $383K | Buy |
766
+68
| +10% | +$34K | 0.17% | 111 |
|
|
2022
Q4 | $285K | Buy |
+698
| New | +$285K | 0.14% | 127 |
|